- The Nasdaq fell 0.07% to close Monday?s session at 15,106.
- Oracle dipped on Q1 revenue drop and shift of focus to cloud-based services.
- Moderna tanked 7% after a report argued against COVID booster shots.
The US markets started the week mixed with energy stocks surging after OPEC said it expects global demand for oil to exceed pre-pandemic levels in 2022 due to increasing vaccination rates and improving confidence in government abilities to overcome the pandemic.
The Dow Jones rose 0.76% to finish the trading day up 262 points to close at 34,870 points.
The tech heavy NASDAQ fell 0.07% to finish the trading day down 10 points to close at 15,106 points.
One bitcoin is worth US$44,963 going into the Asian trading day.
The Australian dollar is firm against the major currencies and is buying 73.69 US cents.
Shares in computer tech company Oracle dipped after the company released first quarter results. For the period, Oracle fell short of revenue expectations, posting results of US$9.73bn, below the expected US$9.77bn, but EPS topped estimates at US$1.03/share. Oracle is focusing more attention on the growing demand for cloud-based services through spending more than US$1bn on infrastructure to meet the demand.
Moderna tumbled 7% on Monday as scientists argued against the booster shot as revealed in a new research paper released. The report said that ?COVID booster shots are not appropriate at this time? which tanked Moderna and other COVID-19 vaccine maker shares as booster shots provide a new revenue stream for the vaccine producers.
And Zoom is adding real-time language translation for 12 different languages next year in a bid to expand usability and relevance as employees return to offices.